Copyright
©The Author(s) 2020.
World J Gastroenterol. Sep 7, 2020; 26(33): 4945-4959
Published online Sep 7, 2020. doi: 10.3748/wjg.v26.i33.4945
Published online Sep 7, 2020. doi: 10.3748/wjg.v26.i33.4945
Table 3 ZO-1 and occludin expressions in colitis
| Group | ZO-1 expression | χ2/P value | Occludin expression | χ2/P value | ||
| Low (%) | High (%) | Low (%) | High (%) | |||
| Control | 6 (50.0%) | 6 (50.0%) | 8.812/0.029 | 7 (58.3%) | 5 (41.7%) | 10.987/0.010 |
| DSS | 7 (77.8%) | 2 (22.2%) | 8 (88.9%) | 1 (11.1%) | ||
| DSS + 5-ASA | 7 (63.6%) | 4 (36.4%) | 9 (81.8%) | 2 (18.2%) | ||
| DSS + RES | 2 (16.7%) | 10 (83.3%) | 3 (25.0%) | 9 (75.0%) | ||
- Citation: Pan HH, Zhou XX, Ma YY, Pan WS, Zhao F, Yu MS, Liu JQ. Resveratrol alleviates intestinal mucosal barrier dysfunction in dextran sulfate sodium-induced colitis mice by enhancing autophagy. World J Gastroenterol 2020; 26(33): 4945-4959
- URL: https://www.wjgnet.com/1007-9327/full/v26/i33/4945.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i33.4945